Dr Steven R Gold, PHD - Medicare Psychologist in Asheville, NC

Dr Steven R Gold, PHD is a medicare enrolled "Psychologist" provider in Asheville, North Carolina. His current practice location is 158 Zillicoa Street, Asheville, North Carolina. You can reach out to his office (for appointments etc.) via phone at (828) 254-9494.

Dr Steven R Gold is licensed to practice in North Carolina (license number 0553) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1558457077.

Contact Information

Dr Steven R Gold, PHD
158 Zillicoa Street,
Asheville, NC 28801-1079
(828) 254-9494
(828) 254-0161



Healthcare Provider's Profile

Full NameDr Steven R Gold
GenderMale
SpecialityPsychologist
Location158 Zillicoa Street, Asheville, North Carolina
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1558457077
  • Provider Enumeration Date: 10/04/2006
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 7416121397
  • Enrollment ID: I20111111000378

Medical Identifiers

Medical identifiers for Dr Steven R Gold such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1558457077NPI-NPPES
045N7OtherNCBCBS OF NC
6000712MedicaidNC
680014753OtherNCMEDICARE RAILROAD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
103T00000XPsychologist 0553 (North Carolina)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Steven R Gold allows following entities to bill medicare on his behalf.
Entity NameInstitute For Applied Neuroscience
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1508141938
PECOS PAC ID: 4183884760
Enrollment ID: O20120320000572

News Archive

Inhibitex completes $23 million private placement of common stock and warrants

Inhibitex, Inc. today reported the completion of its previously announced $23 million private placement of common stock and warrants. Investors in the private placement purchased units, each consisting of one share of common stock and a warrant to purchase .45 of a share of common stock, at a purchase price of $1.28 per unit, which is equal to the consolidated closing bid price of the common stock as reported on the NASDAQ Capital Market for October 22, 2009, plus $0.06.

Researchers to assess any cancer risk associated with low-dose radiation exposure from medical imaging tests

Researchers at the National Institutes of Health (NIH) Clinical Center are incorporating radiation dose exposure reports into the electronic medical record, an effort that they hope will lead to an accurate assessment of whether any cancer risk is associated with low-dose radiation exposure from medical imaging tests, according to an article in the February issue of the Journal of the American College of Radiology (JACR).

"Cadillac Plan" tax: Society of Actuaries proposes changes for successful health care reform

Drawing attention to one of the most complex health care bills recently passed by the U.S. Senate, the Society of Actuaries and American Academy of Actuaries today announced the findings from a new technical model and report on the estimated effect of the excise tax on high–cost employer health plans, also known as the "Cadillac Plan" tax. According to the report, while a tax on excess benefits could play a role in offsetting other costs of health reform, specific design elements of the tax may present some issues.

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Biogen Idec and Swedish Orphan Biovitrum AB today announced results from a Phase 1/2a open-label, dose-escalation, safety and pharmacokinetic study of the companies' long-lasting, fully-recombinant factor IX Fc fusion protein (rFIXFc) in hemophilia B patients. The data, which were presented at the World Federation of Hemophilia Congress in Buenos Aires, Argentina, on July 11, 2010, showed that rFIXFc was well tolerated and demonstrated an approximately three-fold increase in half-life compared to historical data for existing therapies.

Combined endocrine and targeted therapy could be effective in treating Asian breast cancer patients

Ribociclib significantly improves progression-free survival in Asian women with advanced breast cancer, according to a sub-analysis of the MONALEESA-2 trial presented at the ESMO Asia 2016 Congress in Singapore.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Steven R Gold is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Steven R Gold, PHD
158 Zillicoa Street,
Asheville, NC 28801-1079

Ph: (828) 254-9494
Dr Steven R Gold, PHD
158 Zillicoa Street,
Asheville, NC 28801-1079

Ph: (828) 254-9494

News Archive

Inhibitex completes $23 million private placement of common stock and warrants

Inhibitex, Inc. today reported the completion of its previously announced $23 million private placement of common stock and warrants. Investors in the private placement purchased units, each consisting of one share of common stock and a warrant to purchase .45 of a share of common stock, at a purchase price of $1.28 per unit, which is equal to the consolidated closing bid price of the common stock as reported on the NASDAQ Capital Market for October 22, 2009, plus $0.06.

Researchers to assess any cancer risk associated with low-dose radiation exposure from medical imaging tests

Researchers at the National Institutes of Health (NIH) Clinical Center are incorporating radiation dose exposure reports into the electronic medical record, an effort that they hope will lead to an accurate assessment of whether any cancer risk is associated with low-dose radiation exposure from medical imaging tests, according to an article in the February issue of the Journal of the American College of Radiology (JACR).

"Cadillac Plan" tax: Society of Actuaries proposes changes for successful health care reform

Drawing attention to one of the most complex health care bills recently passed by the U.S. Senate, the Society of Actuaries and American Academy of Actuaries today announced the findings from a new technical model and report on the estimated effect of the excise tax on high–cost employer health plans, also known as the "Cadillac Plan" tax. According to the report, while a tax on excess benefits could play a role in offsetting other costs of health reform, specific design elements of the tax may present some issues.

Biogen Idec, Swedish Orphan Biovitrum present results from rFIXFc Phase 1/2a study in hemophilia B

Biogen Idec and Swedish Orphan Biovitrum AB today announced results from a Phase 1/2a open-label, dose-escalation, safety and pharmacokinetic study of the companies' long-lasting, fully-recombinant factor IX Fc fusion protein (rFIXFc) in hemophilia B patients. The data, which were presented at the World Federation of Hemophilia Congress in Buenos Aires, Argentina, on July 11, 2010, showed that rFIXFc was well tolerated and demonstrated an approximately three-fold increase in half-life compared to historical data for existing therapies.

Combined endocrine and targeted therapy could be effective in treating Asian breast cancer patients

Ribociclib significantly improves progression-free survival in Asian women with advanced breast cancer, according to a sub-analysis of the MONALEESA-2 trial presented at the ESMO Asia 2016 Congress in Singapore.

Read more News

› Verified 6 days ago


Psychologist in Asheville, NC

Dr. Emily C Gordon, PHD CLINICAL PSYCHOL
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 540 Aiken Rd, Asheville, NC 28804
Phone: 828-645-1539    
Karen Marcus,
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 30 Clayton St, Asheville, NC 28801
Phone: 828-258-1700    
Elizabeth Sarah Conder, PH.D.
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 1 Oak Plz, Suite 206, Asheville, NC 28801
Phone: 828-252-2501    Fax: 828-252-2701
Dr. Christopher Sanmiguel, PH.D.
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 1100 Tunnel Rd, Mental Health Clinic, Asheville, NC 28805
Phone: 828-299-2519    
Edward Richards Johnston Iii, LPA
Psychologist
Medicare: Not Enrolled in Medicare
Practice Location: 111 Mcdowell St, Asheville, NC 28801
Phone: 828-412-3144    Fax: 828-782-3002
Dr. Susan L Hill, ED.D
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 158 Zillicoa St, Asheville, NC 28801
Phone: 828-254-9494    Fax: 828-254-0161
Dr. Daniel H Cogswell, PH.D.
Psychologist
Medicare: Accepting Medicare Assignments
Practice Location: 158 Zillicoa Street, Asheville, NC 28801
Phone: 828-254-9494    Fax: 828-254-0161

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.